DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar scrubs620 (< 20) Submitted: 9/12/2007 8:56:27 PM : Outperform Start Price: $62.20 DVA Score: +37.84

Breakout of basing pattern on above average volume. Target $80

Featured Broker Partners


Advertisement